Product Pipeline

iCeutica is internally developing a pipeline of products which it aims to launch itself, or with pharmaceutical marketing partners.

The leading two internal clinical products under development are reformulations of a powerful pain and inflammation drug (meloxicam) and a muscle relaxant (metaxalone).

The Company has also licensed out three products to an American pharmaceutical company, Iroko Pharmaceuticals, LLC. Iroko is currently preparing two of these products for Phase III trials and the third product for Phase I trials.